Imunon, Inc. — Director's Dealing 2016

Oct 11, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2016-10-07

Reporting Person: Tardugno Michael H (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-07	Celsion Corporation Common Stock	P	10000	$1.14	Acquired	143021	Direct

Footnotes

F1: The Chairman, President and Chief Executive Officer purchased the shares on the open market